Antidiabetic agents and dementia risk in type 2 diabetes: A systematic review and network meta‐analysis

Documenti analoghi

• Bifidobacterium bifidum G9‐1 Intake Improves Gastrointestinal Symptoms in Type 2 Diabetes Mellitus: An Open‐Label, Randomized Controlled Trial (Binary STAR Study)
  di: Genki Kobayashi, et al.
  Pubblicazione: (2026)
• Antidiabetic and lipid‐lowering medication use inversely linked with serum biomarkers of liver fibrosis
  di: Jun Wang, et al.
  Pubblicazione: (2025)
• Impact of an online nutrition management application service on glycaemic management in individuals with diabetes: A propensity‐score‐matched retrospective cohort study
  di: Junya Hironaka, et al.
  Pubblicazione: (2024)
• Risk of insulin initiation with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes mellitus: A real‐world claims database study in Japan
  di: Ryo Suzuki, et al.
  Pubblicazione: (2025)
• Comparison of renal prognosis between dipeptidyl peptidase‐4 inhibitor users and non‐users
  di: Hideaki Hashimoto, et al.
  Pubblicazione: (2024)